Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis

NCT02894684 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis
Infection
Pseudomonas

Interventions

DRUG: Aztreonam
DRUG: Standard Care

Sponsor

Liverpool Heart and Chest Hospital NHS Foundation Trust

Collaborators

[object Object]